Paper42477458
Splicing-mediated control of hnRNPD isoform switching by SRSF2 drives PD-L1-dependent immune evasion in gallbladder cancer.
Zhao C and 11 others. Oncogene, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Splicing-mediated control of hnRNPD isoform switching by SRSF2 drives PD-L1-dependent immune evasion in gallbladder cancer. Papers, record 42477458. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42477458
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Splicing-mediated control of hnRNPD isoform switching by SRSF2 drives PD-L1-dependent immune evasion in gallbladder cancer.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gallbladder Neoplasms | Major topic |
| Serine-Arginine Splicing Factors | Major topic |
| B7-H1 Antigen | Major topic |
| Alternative Splicing | Major topic |
| Heterogeneous Nuclear Ribonucleoprotein D0 | Major topic |
| Heterogeneous-Nuclear Ribonucleoprotein D | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Gene Expression Regulation, Neoplastic | |
| Cell Line, Tumor | |
| Protein Isoforms |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82472646 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 82403040 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 82173081 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 82403527 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 42773214 | Correction: Splicing-mediated control of hnRNPD isoform switching by SRSF2 drives PD-L1-dependent immune evasion in gallbladder cancer. | https://conductscience.org/library/papers/42773214 |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28488700 | Alternative splicing as a regulator of development and tissue identity. | Nat Rev Mol Cell Biol | 2017 | https://conductscience.org/library/papers/28488700 | PubMed |
| 2 | 35661964 | TERC suppresses PD-L1 expression by downregulating RNA binding protein HuR. | Sci China Life Sci | 2022 | https://conductscience.org/library/papers/35661964 | PubMed |
| 3 | 36949200 | RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer. | Nature | 2023 | https://conductscience.org/library/papers/36949200 | PubMed |
| 4 | 38576051 | RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma. | J Exp Clin Cancer Res | 2024 | https://conductscience.org/library/papers/38576051 | PubMed |
| 5 | 37993451 | The BRD4-SRPK2-SRSF2 signal modulates the splicing efficiency of ACSL3 pre-mRNA and influences erastin-induced ferroptosis in osteosarcoma cells. | Cell Death Dis | 2023 | https://conductscience.org/library/papers/37993451 | PubMed |
| 6 | 39248331 | SRSF2 is a key player in orchestrating the directional migration and differentiation of MyoD progenitors during skeletal muscle development. | Elife | 2024 | https://conductscience.org/library/papers/39248331 | PubMed |
| 7 | 8647811 | AUF1 binding affinity to A+U-rich elements correlates with rapid mRNA degradation. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8647811 | PubMed |
| 8 | 37366237 | Regulation of LRRK2 mRNA stability by ATIC and its substrate AICAR through ARE-mediated mRNA decay in Parkinson's disease. | EMBO J | 2023 | https://conductscience.org/library/papers/37366237 | PubMed |
| 9 | 25784052 | Mechanisms and Regulation of Alternative Pre-mRNA Splicing. | Annu Rev Biochem | 2015 | https://conductscience.org/library/papers/25784052 | PubMed |
| 10 | 40175650 | Alternative splicing of bunched confers a dual role in hippo pathway-dependent growth and tumorigenesis. | Oncogene | 2025 | https://conductscience.org/library/papers/40175650 | PubMed |
| 11 | 38489268 | DDX3 regulates cancer immune surveillance via 3' UTR-mediated cell-surface expression of PD-L1. | Cell Rep | 2024 | https://conductscience.org/library/papers/38489268 | PubMed |
| 12 | 29246442 | Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA. | Immunity | 2017 | https://conductscience.org/library/papers/29246442 | PubMed |
| 13 | 39116343 | PTBP3 Mediates IL-18 Exon Skipping to Promote Immune Escape in Gallbladder Cancer. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/39116343 | PubMed |
| 14 | 38161240 | The role of secondary structures in the functioning of 3' untranslated regions of mRNA: A review of functions of 3' UTRs' secondary structures and hypothetical involvement of secondary structures in cytoplasmic polyadenylation in Drosophila. | Bioessays | 2024 | https://conductscience.org/library/papers/38161240 | PubMed |
| 15 | 21514162 | Pre-mRNA splicing: where and when in the nucleus. | Trends Cell Biol | 2011 | https://conductscience.org/library/papers/21514162 | PubMed |
| 16 | 38719336 | Comprehensive single-cell analysis deciphered microenvironmental dynamics and immune regulator olfactomedin 4 in pathogenesis of gallbladder cancer. | Gut | 2024 | https://conductscience.org/library/papers/38719336 | PubMed |
| 17 | 36052238 | Successful conversion surgery for locally advanced gallbladder cancer after gemcitabine and nab-paclitaxel chemotherapy. | Front Oncol | 2022 | https://conductscience.org/library/papers/36052238 | PubMed |
| 18 | 40270362 | Targeting PTBP3-Mediated Alternative Splicing of COX11 Induces Cuproptosis for Inhibiting Gastric Cancer Peritoneal Metastasis. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40270362 | PubMed |
| 19 | 9521873 | Structure and genomic organization of the human AUF1 gene: alternative pre-mRNA splicing generates four protein isoforms. | Genomics | 1998 | https://conductscience.org/library/papers/9521873 | PubMed |
| 20 | 35654793 | Comprehensive characterization of posttranscriptional impairment-related 3'-UTR mutations in 2413 whole genomes of cancer patients. | NPJ Genom Med | 2022 | https://conductscience.org/library/papers/35654793 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| HNRNPD | 3184 | PubTator's text mining | https://conductscience.org/library/genes/3184 | NCBI Gene |
| NFE2 | 4778 | PubTator's text mining | https://conductscience.org/library/genes/4778 | NCBI Gene |
| SRSF2 | 6427 | PubTator's text mining | https://conductscience.org/library/genes/6427 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42477458
GET https://conductscience.org/api/papers/v1/42477458/references?page=2